Dana-Farber Cancer Institute, Boston Children’s Hospital, and Broad Clinical Labs form BrightSeq collaborative to develop novel clinical diagnostic assays for rare pediatric cancers.
Read More
Breath tests are increasingly being explored and implemented in clinical diagnosis, offering a non-invasive means to detect a variety of conditions like blood cancer, lung disease, lower respiratory tract infections, and gastroparesis.
Read More
Despite powerful advances in precision medicine, most doctors remain untrained in these emerging diagnostic tools.
Read More
A new study reveals that a simple blood test using single-cell sequencing of rare stem cells can detect early signs of leukemia.
Read More
NGS-based MRD testing offers unprecedented sensitivity and breadth in detecting low-frequency leukemic clones.
Read More